Skip to main content
Erschienen in: Digestive Diseases and Sciences 4/2024

15.02.2024 | Original Article

Homeobox Protein BarH-like 1 Promotes Gastric Cancer Progression by Activating Coiled-Coil Domain-Containing Protein 178

verfasst von: Yue Gu, Gang Chen, Xinwei Ning

Erschienen in: Digestive Diseases and Sciences | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Coiled-coil domain-containing protein 178 (CCDC178) has been revealed to exert metastasis-promoting properties in hepatocellular carcinoma, whereas its function in gastric cancer (GC) has not been fully understood.

Aims

We evaluated its role in GC and the molecular mechanism.

Methods

The differentially expressed genes in datasets related to GC metastasis were intersected with survival-related genes in GC, followed by prognostic significance prediction. Loss- and gain-of-function assays were conducted to examine the involvement of CCDC178, Homeobox protein BarH-like 1 (BARX1), and the extracellular signal-regulated kinase (ERK) pathway in GC cell malignant phenotype and the polarization of tumor-associated macrophages (TAM). The corresponding functions were verified in the in vivo animal experiment.

Results

High CCDC178 expression predicted a poor prognosis for GC patients, and CCDC178 correlated significantly with macrophage infiltration in GC tissues. CCDC178 activated the ERK pathway in GC. Silencing of CCDC178 reduced the colony formation, migratory and invasive potential of GC cells, and the M2-like polarization of TAM, which was reversed by TBHQ (an ERK activator). BARX1 bound to the promoter region of CCDC178, thus inducing its transcriptional level. Silencing of BARX1 suppressed the M2-type polarization of TAM in vitro and in vivo, and CCDC178 mitigated the repressing role of BARX1 knockdown.

Conclusions

BARX1 activates the transcription of CCDC178 to induce the ERK pathway, thereby supporting macrophage recruitment and M2-like polarization in GC.

Graphical Abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Seeneevassen L, Bessede E, Megraud F, Lehours P, Dubus P, Varon C. Gastric Cancer: Advances in Carcinogenesis Research and New Therapeutic Strategies. Int J Mol Sci. 2021;22.CrossRefPubMedPubMedCentral Seeneevassen L, Bessede E, Megraud F, Lehours P, Dubus P, Varon C. Gastric Cancer: Advances in Carcinogenesis Research and New Therapeutic Strategies. Int J Mol Sci. 2021;22.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635–648.CrossRefPubMed Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635–648.CrossRefPubMed
3.
Zurück zum Zitat Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39:1179–1203.CrossRefPubMedPubMedCentral Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39:1179–1203.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Hu X, Zhao Y, Wei L, Zhu B, Song D, Wang J et al. CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis. Oncogene. 2017;36:4047–4059.CrossRefPubMed Hu X, Zhao Y, Wei L, Zhu B, Song D, Wang J et al. CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis. Oncogene. 2017;36:4047–4059.CrossRefPubMed
5.
Zurück zum Zitat Liu Z, Yan W, Liu S, Liu Z, Xu P, Fang W. Regulatory network and targeted interventions for CCDC family in tumor pathogenesis. Cancer Lett. 2023;565:216225.CrossRefPubMed Liu Z, Yan W, Liu S, Liu Z, Xu P, Fang W. Regulatory network and targeted interventions for CCDC family in tumor pathogenesis. Cancer Lett. 2023;565:216225.CrossRefPubMed
6.
Zurück zum Zitat Wang Z, Zhang H, Zhai Y, Li F, Shi X, Ying M. Single-Cell Profiling Reveals Heterogeneity of Primary and Lymph Node Metastatic Tumors and Immune Cell Populations and Discovers Important Prognostic Significance of CCDC43 in Oral Squamous Cell Carcinoma. Front Immunol. 2022;13:843322.CrossRefPubMedPubMedCentral Wang Z, Zhang H, Zhai Y, Li F, Shi X, Ying M. Single-Cell Profiling Reveals Heterogeneity of Primary and Lymph Node Metastatic Tumors and Immune Cell Populations and Discovers Important Prognostic Significance of CCDC43 in Oral Squamous Cell Carcinoma. Front Immunol. 2022;13:843322.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Zeng D, Li M, Zhou R, Zhang J, Sun H, Shi M et al. Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures. Cancer Immunol Res. 2019;7:737–750.CrossRefPubMed Zeng D, Li M, Zhou R, Zhang J, Sun H, Shi M et al. Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures. Cancer Immunol Res. 2019;7:737–750.CrossRefPubMed
8.
Zurück zum Zitat Gambardella V, Castillo J, Tarazona N, Gimeno-Valiente F, Martinez-Ciarpaglini C, Cabeza-Segura M et al. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target. Cancer Treat Rev. 2020;86:102015.CrossRefPubMed Gambardella V, Castillo J, Tarazona N, Gimeno-Valiente F, Martinez-Ciarpaglini C, Cabeza-Segura M et al. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target. Cancer Treat Rev. 2020;86:102015.CrossRefPubMed
10.
11.
Zurück zum Zitat Ma F, Zhang B, Ji S, Hu H, Kong Y, Hua Y et al. Hypoxic Macrophage-Derived VEGF Promotes Proliferation and Invasion of Gastric Cancer Cells. Dig Dis Sci. 2019;64:3154–3163.CrossRefPubMed Ma F, Zhang B, Ji S, Hu H, Kong Y, Hua Y et al. Hypoxic Macrophage-Derived VEGF Promotes Proliferation and Invasion of Gastric Cancer Cells. Dig Dis Sci. 2019;64:3154–3163.CrossRefPubMed
12.
Zurück zum Zitat Luo M, Deng S, Han T, Ou Y, Hu Y. LncRNA NR2F2-AS1 functions as a tumor suppressor in gastric cancer through targeting miR-320b/PDCD4 pathway. Histol Histopathol. 2022;37:575–585.PubMed Luo M, Deng S, Han T, Ou Y, Hu Y. LncRNA NR2F2-AS1 functions as a tumor suppressor in gastric cancer through targeting miR-320b/PDCD4 pathway. Histol Histopathol. 2022;37:575–585.PubMed
13.
Zurück zum Zitat J DEFFBDC, C DECSA, Muniz J, CAM DAR, Lamarao LM, C DEFAMN et al. Deregulation of the SRC Family Tyrosine Kinases in Gastric Carcinogenesis in Non-human Primates. Anticancer Res. 2018;38:6317–6320.CrossRef J DEFFBDC, C DECSA, Muniz J, CAM DAR, Lamarao LM, C DEFAMN et al. Deregulation of the SRC Family Tyrosine Kinases in Gastric Carcinogenesis in Non-human Primates. Anticancer Res. 2018;38:6317–6320.CrossRef
16.
Zurück zum Zitat Piao H, Fu L, Wang Y, Liu Y, Wang Y, Meng X et al. A positive feedback loop between gastric cancer cells and tumor-associated macrophage induces malignancy progression. J Exp Clin Cancer Res. 2022;41:174.CrossRefPubMedPubMedCentral Piao H, Fu L, Wang Y, Liu Y, Wang Y, Meng X et al. A positive feedback loop between gastric cancer cells and tumor-associated macrophage induces malignancy progression. J Exp Clin Cancer Res. 2022;41:174.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Wang Y, Wang Y, Zhou J, Ying P, Wang Z, Wu Y et al. A novel coiled-coil domain containing-related gene signature for predicting prognosis and treatment effect of breast cancer. J Cancer Res Clin Oncol. 2023.CrossRefPubMed Wang Y, Wang Y, Zhou J, Ying P, Wang Z, Wu Y et al. A novel coiled-coil domain containing-related gene signature for predicting prognosis and treatment effect of breast cancer. J Cancer Res Clin Oncol. 2023.CrossRefPubMed
18.
19.
Zurück zum Zitat Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21:607–632.CrossRefPubMed Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21:607–632.CrossRefPubMed
20.
Zurück zum Zitat Li JP, Lin CW, Huang CC, Lu YT, Ho YT, Yang SF et al. Lipocalin 2 Reduces MET Levels by Inhibiting MEK/ERK Signaling to Inhibit Nasopharyngeal Carcinoma Cell Migration. Cancers (Basel). 2022;14.CrossRefPubMed Li JP, Lin CW, Huang CC, Lu YT, Ho YT, Yang SF et al. Lipocalin 2 Reduces MET Levels by Inhibiting MEK/ERK Signaling to Inhibit Nasopharyngeal Carcinoma Cell Migration. Cancers (Basel). 2022;14.CrossRefPubMed
21.
Zurück zum Zitat Guo L, Li B, Lu Z, Liang H, Yang H, Chen Y et al. CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis. Front Mol Biosci. 2021;8:674863.CrossRefPubMedPubMedCentral Guo L, Li B, Lu Z, Liang H, Yang H, Chen Y et al. CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis. Front Mol Biosci. 2021;8:674863.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Locati M, Curtale G, Mantovani A. Diversity, Mechanisms, and Significance of Macrophage Plasticity. Annu Rev Pathol. 2020;15:123–147.CrossRefPubMed Locati M, Curtale G, Mantovani A. Diversity, Mechanisms, and Significance of Macrophage Plasticity. Annu Rev Pathol. 2020;15:123–147.CrossRefPubMed
23.
Zurück zum Zitat Wang J, Wu X, Dai W, Li J, Xiang L, Tang W et al. The CCDC43-ADRM1 axis regulated by YY1, promotes proliferation and metastasis of gastric cancer. Cancer Lett. 2020;482:90–101.CrossRefPubMed Wang J, Wu X, Dai W, Li J, Xiang L, Tang W et al. The CCDC43-ADRM1 axis regulated by YY1, promotes proliferation and metastasis of gastric cancer. Cancer Lett. 2020;482:90–101.CrossRefPubMed
24.
Zurück zum Zitat Liu H, Zhou L, Cheng H, Wang S, Luan W, Cai E et al. Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer. Chin Med J (Engl). 2023.CrossRefPubMed Liu H, Zhou L, Cheng H, Wang S, Luan W, Cai E et al. Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer. Chin Med J (Engl). 2023.CrossRefPubMed
25.
Zurück zum Zitat Hemming ML, Coy S, Lin JR, Andersen JL, Przybyl J, Mazzola E et al. HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor. Clin Cancer Res. 2021;27:1706–1719.CrossRefPubMedPubMedCentral Hemming ML, Coy S, Lin JR, Andersen JL, Przybyl J, Mazzola E et al. HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor. Clin Cancer Res. 2021;27:1706–1719.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Yan C, Ji Y, Huang T, Yu F, Gao Y, Gu Y et al. An esophageal adenocarcinoma susceptibility locus at 9q22 also confers risk to esophageal squamous cell carcinoma by regulating the function of BARX1. Cancer Lett. 2018;421:103–111.CrossRefPubMed Yan C, Ji Y, Huang T, Yu F, Gao Y, Gu Y et al. An esophageal adenocarcinoma susceptibility locus at 9q22 also confers risk to esophageal squamous cell carcinoma by regulating the function of BARX1. Cancer Lett. 2018;421:103–111.CrossRefPubMed
27.
Zurück zum Zitat Huang X, Wang Z, Zhang J, Ni X, Bai G, Cao J et al. BARX1 promotes osteosarcoma cell proliferation and invasion by regulating HSPA6 expression. J Orthop Surg Res. 2023;18:211.CrossRefPubMedPubMedCentral Huang X, Wang Z, Zhang J, Ni X, Bai G, Cao J et al. BARX1 promotes osteosarcoma cell proliferation and invasion by regulating HSPA6 expression. J Orthop Surg Res. 2023;18:211.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Lu Y, Lu H, Yang X, Song W. BarH-like homeobox 1 induces the progression of cell malignant phenotype in endometrial carcinoma through the regulation of ERK/MEK signaling pathway. Reprod Biol. 2021;21:100502.CrossRefPubMed Lu Y, Lu H, Yang X, Song W. BarH-like homeobox 1 induces the progression of cell malignant phenotype in endometrial carcinoma through the regulation of ERK/MEK signaling pathway. Reprod Biol. 2021;21:100502.CrossRefPubMed
Metadaten
Titel
Homeobox Protein BarH-like 1 Promotes Gastric Cancer Progression by Activating Coiled-Coil Domain-Containing Protein 178
verfasst von
Yue Gu
Gang Chen
Xinwei Ning
Publikationsdatum
15.02.2024
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 4/2024
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-024-08312-0

Weitere Artikel der Ausgabe 4/2024

Digestive Diseases and Sciences 4/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.